Legaba-NT Tablet contains a combination of Gabapentin 400 mg and Nortriptyline 10 mg, formulated for the management of neuropathic pain and certain neurological disorders. Gabapentin, an anticonvulsant, modulates calcium channels to reduce neuronal excitability, thereby alleviating neuropathic pain and preventing seizures. Nortriptyline, a tricyclic antidepressant, exerts analgesic effects by inhibiting the reuptake of norepinephrine and serotonin, enhancing descending inhibitory pain pathways. The synergistic action of these agents provides effective relief in conditions such as diabetic neuropathy, postherpetic neuralgia, and other chronic neuropathic pain syndromes. Legaba-NT is typically prescribed when monotherapy is insufficient, offering improved pain control and enhanced patient quality of life. The tablet should be administered orally as directed by a healthcare professional, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include dizziness, drowsiness, dry mouth, and gastrointestinal discomfort. Caution is advised in patients with renal impairment, cardiac conditions, or a history of seizures. Concomitant use with CNS depressants should be monitored to avoid additive sedation. Legaba-NT is contraindicated in individuals with hypersensitivity to gabapentin, nortriptyline, or related compounds. Regular follow-up is recommended to assess therapeutic efficacy and monitor for potential side effects.